Recommendations of the Spanish Society of Pediatric Cardiology and Congenital Heart Diseases for the prevention of respiratory syncytial virus infections with nirsevimab in pediatric cardiology

An Pediatr (Engl Ed). 2024 Feb;100(2):148-150. doi: 10.1016/j.anpede.2023.10.011. Epub 2024 Jan 19.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Cardiology*
  • Child
  • Heart Defects, Congenital*
  • Humans
  • Respiratory Syncytial Virus Infections* / drug therapy
  • Respiratory Syncytial Virus Infections* / prevention & control

Substances

  • nirsevimab
  • Antibodies, Monoclonal, Humanized